Your session is about to expire
← Back to Search
Study Summary
This trial is designed to find the best way to help very young autistic children who have very little language. It will adapt to each child's needs, potentially reducing the burden on the children.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I likely haven't been exposed to AAC.My child has been diagnosed with autism.I am between 3 and 5 years old.I do not have sensory, motor impairments, or known genetic syndromes.You have certain changes in your genes that can be treated with medication.My child has been in early intervention or preschool for over 3 months.
- Group 1: JASPER
- Group 2: DTT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open slots for participants in this trial?
"This clinical trial is still recruiting according to information on the website, clinicialtrials.gov. It was first posted in March 2021 and its most recent update was in August of this year."
Is participation in this experiment open to individuals of all ages, or is there an age limitation?
"This research project permits individuals aged between 36 months and 59 months to sign up for the trial. There are 228 studies available for minors, whereas elderly persons can participate in 42 distinct trials."
Is there any way for me to be included in this experiment?
"This autism spectrum disorder trial is seeking 140 children aged between 36-59 months and who have had more than 3 months of early interventions. The applicant must also use less than 20 functional words, maintain a stable medication regimen for the preceding 6 months and attain nonverbal mental age scores above 12 on the Mullen Scales of Early Learning (visual reception and fine motor subscales)."
How many subjects are engaged in this medical trial?
"This trial necessitates an enrollment of 140 eligible patients from multiple medical sites, including University of Oregon in Eugene and UCLA in Los Angeles."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger